CHICAGO – PePRS study provides much-needed pediatric evidence in GPA and MPA.
A novel drug affecting the GABAergic system improved sleep problems in a sample of adults and adolescents with Angelman Syndrome.
Patients with Lennox-Gastaut syndrome can have difficulty swallowing pills or large-volume oral suspensions, so this oral film may reduce care...
WASHINGTON – Many pediatric indications involve genetic disorders.
From the Journals
News from the FDA/CDC
The central nervous system depressant was approved for the treatment of cataplexy and excessive daytime sleepiness.
WASHINGTON – Most patients with opsoclonus myoclonus syndrome experience ataxia, among multiple other symptoms.
The safety profile was fairly similar to that seen with intravenous formulations.